GTBP
Price
$5.52
Change
+$0.11 (+2.03%)
Updated
Oct 22 closing price
Capitalization
9.96M
22 days until earnings call
Intraday BUY SELL Signals
MDGL
Price
$453.34
Change
-$4.62 (-1.01%)
Updated
Oct 22 closing price
Capitalization
10.47B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GTBP vs MDGL

GTBP vs MDGL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GTBP vs. MDGL commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBP is a StrongBuy and MDGL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GTBP with price predictions
Oct 22, 2026

GTBP in upward trend: price may jump up because it broke its lower Bollinger Band on October 21, 2026

GTBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 45 of 52 cases where GTBP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GTBP just turned positive on October 08, 2026. Looking at past instances where GTBP's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.

Following a +14.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where GTBP advanced for three days, in 168 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 32 cases where GTBP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GTBP as a result. In 107 of 113 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The 10-day moving average for GTBP crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GTBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.792) is normal, around the industry mean (2.973). P/E Ratio (0.042) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. GTBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GTBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for MDGL with price predictions
Oct 22, 2026

MDGL in downward trend: 10-day moving average moved below 50-day moving average on September 23, 2026

The 10-day moving average for MDGL crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

MDGL moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDGL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for MDGL entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MDGL's RSI Oscillator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 64 cases where MDGL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

Following a +0.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDGL advanced for three days, in 222 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

MDGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.999) is normal, around the industry mean (2.973). P/E Ratio (-32.405) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (9.443) is also within normal values, averaging (438.009).

The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. MDGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
GTBP vs MDGL: Fundamental Ratings
GTBP
MDGL
OUTLOOK RATING
1..100
354
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
11
Undervalued
PROFIT vs RISK RATING
1..100
10021
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8762
P/E GROWTH RATING
1..100
125
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDGL's Valuation (11) in the Pharmaceuticals Other industry is somewhat better than the same rating for GTBP (71) in the null industry. This means that MDGL’s stock grew somewhat faster than GTBP’s over the last 12 months.

MDGL's Profit vs Risk Rating (21) in the Pharmaceuticals Other industry is significantly better than the same rating for GTBP (100) in the null industry. This means that MDGL’s stock grew significantly faster than GTBP’s over the last 12 months.

MDGL's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as GTBP (100) in the null industry. This means that MDGL’s stock grew similarly to GTBP’s over the last 12 months.

MDGL's Price Growth Rating (62) in the Pharmaceuticals Other industry is in the same range as GTBP (87) in the null industry. This means that MDGL’s stock grew similarly to GTBP’s over the last 12 months.

GTBP's P/E Growth Rating (1) in the null industry is in the same range as MDGL (25) in the Pharmaceuticals Other industry. This means that GTBP’s stock grew similarly to MDGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBPMDGL
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 25 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
70%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (GTBP: $5.41 vs. MDGL: $457.96)
Brand notoriety: GTBP and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GTBP: 69% vs. MDGL: 114%
Market capitalization -- GTBP: $9.96M vs. MDGL: $10.47B
GTBP [@Biotechnology] is valued at $9.96M. MDGL’s [@Biotechnology] market capitalization is $10.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBP’s FA Score shows that 1 FA rating(s) are green while MDGL’s FA Score has 3 green FA rating(s).

  • GTBP’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 3 green, 2 red.
According to our system of comparison, MDGL is a better buy in the long-term than GTBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBP’s TA Score shows that 3 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • GTBP’s TA Score: 3 bullish, 4 bearish.
  • MDGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than GTBP.

Price Growth

GTBP (@Biotechnology) experienced а -12.88% price change this week, while MDGL (@Biotechnology) price change was -0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

GTBP is expected to report earnings on Nov 13, 2026.

MDGL is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
GTBP
Daily Signal:
Gain/Loss:
MDGL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

GTBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with SLGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBP
1D Price
Change %
GTBP100%
+2.03%
SLGL - GTBP
33%
Loosely correlated
+2.54%
AMRN - GTBP
33%
Poorly correlated
+0.78%
MDGL - GTBP
32%
Poorly correlated
-1.01%
VKTX - GTBP
31%
Poorly correlated
-2.08%
XBIO - GTBP
31%
Poorly correlated
-2.53%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with ALXO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then ALXO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-1.01%
ALXO - MDGL
56%
Loosely correlated
+3.48%
IPHA - MDGL
44%
Loosely correlated
-3.82%
LCTX - MDGL
43%
Loosely correlated
+3.52%
CVM - MDGL
43%
Loosely correlated
-0.62%
VOR - MDGL
42%
Loosely correlated
N/A
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSPS31.951.11
+3.58%
Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)
XTAP46.97N/A
N/A
Innovator U.S. Equity Accelerated Plus ETF (XTAP)
PDX20.09-0.21
-1.03%
PIMCO Dynamic Income Strategy Fund
AVNV82.50-1.44
-1.71%
Avantis All International Markets Value ETF (AVNV)
QQQ704.47-20.73
-2.86%
Invesco QQQ Trust Series I (QQQ)